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Objective: The purpose of this study was to identify risk factors associated with the
onset of atrial fibrillation after thoracic surgery to allow more targeted interventions
in patients with the highest risk.
Methods: A comprehensive prospective database was used to identify patients
undergoing major thoracic surgery from January 1, 1998, through December 31,
2002. Data collection was performed at point of contact: at preoperative evaluation,
the time of the operation, discharge, and postoperative visits. All patients undergo-
ing resection of a lung, the esophagus, the chest wall, or a mediastinal mass were
included in this study. Univariate and multivariate analyses of factors associated
with the development of atrial fibrillation were analyzed.
Results: There were 2588 patients who met the inclusion criteria. The overall
incidence of atrial fibrillation was 12.3% (n  319). Categories of disease were
primary lung cancer, pulmonary metastasis, esophageal cancer, intrathoracic me-
tastasis, benign lung disease, other mediastinal tumors, mesothelioma, chest wall
tumors, benign esophagus, and “other.” Patients with atrial fibrillation had increased
mean lengths of hospital stay, mortality rates, and mean hospital charges. Univariate
analysis evaluated age, sex, disease category, comorbidities, preoperative therapy,
and procedure, and significant variables were entered into the multivariate analysis.
Significant variables (relative risk; 95% confidence interval) in the multivariate
analysis were male sex (1.72; 1.29-2.28), age 50 to 59 years (1.70; 1.01-2.88), age
60 to 69 years (4.49; 2.79-7.22), age 70 years or greater (5.30; 3.28-8.59), history
of congestive heart failure (2.51; 1.06-6.24), history of arrhythmias (1.92; 1.22-
3.02), history of peripheral vascular disease (1.65; 0.93-2.92), resection of medias-
tinal tumor or thymectomy (2.36; 0.95-5.88), lobectomy (3.89; 2.19-6.91), bilobec-
tomy (7.16; 3.02-16.96), pneumonectomy (8.91; 4.59-17.28), esophagectomy (2.95;
1.55-5.62), and intraoperative transfusions (1.39; 0.98-1.98).
Conclusions: The significant variables identified by means of multivariate analysis
were associated with the occurrence of atrial fibrillation. Preventive therapies in
selected populations might reduce the incidence of atrial fibrillation.
Since initially reported by Bailey and Betts1 in 1943, supraventriculartachyrhythmias, particularly atrial fibrillation (AF), have remainedone of the most frequent complications that occur after noncardiacthoracic surgery. The occurrence of AF is associated with substantialmorbidity, such as increased hospital stay, risk of stroke, postopera-tive mortality, and significant increases in cost.2-6 Efforts to prevent
AF have included multiple pharmacologic attempts at prophylaxis, with partial
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success.7-10 In addition, new implantable cardioversion
techniques are becoming available.11 These medications
and cardioversion techniques involve some risk and in-
crease costs. Therefore identification of all high-risk popu-
lations will allow targeted use and hence more cost-effec-
tive and successful application of these methods.
A number of attempts at identifying risk factors for
postoperative AF have been made.2,4,5,12-16 These studies
have identified age and extent of pulmonary resection as
apparent risk factors. However, these studies have examined
small numbers of patients or specific groups of patients,
such as those undergoing selected surgical procedures or
with a specific diagnosis. The applicability of these findings
to all patients encountered in a general noncardiac thoracic
surgery practice is limited. The relative contributions of
chest wall resection, mediastinal tumor resection, metasta-
sectomy, and esophagectomy to the risk of AF are less
clearly understood. A more comprehensive assessment of
the risk of AF in all patients undergoing noncardiac thoracic
surgery could determine the roles that these events play. The
purpose of this study was to identify preoperative and
intraoperative factors that are associated with an increased
risk of postoperative AF in patients undergoing noncardiac
thoracic surgery.
Methods
Patients were selected from a comprehensive, prospective database
initiated by our department in January 1998 that includes all
patients undergoing major thoracic surgery at The University of
Texas M. D. Anderson Cancer Center. Physicians, physician as-
sistants, and nurse extenders involved in patient care collect data at
point of contact, which is defined as the following: at the comple-
tion of the preoperative evaluation, at the time of the operation, on
the day of discharge, and at every postoperative outpatient encoun-
ter. The database is part of our department’s quality-improvement
program. Although comprehensive, it was not established for the
specific goal of identifying risk factors associated with the devel-
opment of AF but rather as a means of investigating a wide variety
of questions. Therefore this constitutes a retrospective review.
However, the prospective data collection should minimize the
biases and errors associated with retrospective data collection. The
use of this database for clinical research has been approved by our
institutional review board.
All patients, regardless of diagnosis, who underwent resection
of the lung, the esophagus, the chest wall, or a mediastinal mass
from January 1, 1998, through December 31, 2002, were included
in this analysis. Information was recorded in the database about
demographics, comorbidity, medical and surgical histories, preop-
erative functional testing, operative details, postoperative events,
and long-term symptomatic and oncologic outcomes. During this
4-year period, the database was modified by the addition of further
data-entry fields to collect more detailed information about each
patient. Consequently, some of the patients who were enrolled
early in the database had incomplete data relative to more recently
entered patients. Only those data that were collected throughout
the entire 4-year study period were included in the analysis.
The demographic data that we analyzed were patient age, sex,
and category of disease. Preoperative and perioperative factors
examined were weight loss, neoadjuvant therapy, smoking history,
timing of smoking cessation relative to the operation, alcohol use
(defined as 4 oz/d or its equivalent), hypertension, congestive
heart failure, angina, prior myocardial infarction, arrhythmia, di-
abetes, peripheral vascular disease, chronic obstructive pulmonary
disease (COPD; defined as a disease requiring chronic bronchodi-
lator use), prior cardiothoracic surgery, prior cardiac surgery, prior
thoracotomy, procedure performed, mediastinal lymph node dis-
section, and intraoperative transfusions (defined as the use of any
blood products intraoperatively).
All patients had continuous telemetric monitoring of electro-
cardiography and oxygen saturation for at least the first 72 hours
after resection. No routine prophylaxis for AF was in place during
the study period, with the exception of a small number of patients
undergoing extrapleural pneumonectomy. To identify clinically
relevant episodes of AF or atrial flutter, our database definition of
AF is a sustained or repetitive electrocardiographically docu-
mented AF or atrial flutter that requires initiation of antiarrhythmic
therapy. Data on 30-day mortality rates, length of hospital stay,
and hospital charges were also collected.
Statistical analysis consisted of univariate analysis of all vari-
ables. All variables were treated as categoric. Variables with a P
value of less than .25 were entered into a multivariate logistic
regression model. A stepwise backward elimination using the
likelihood ratio test with elimination defined by a P value of .1 or
greater was performed. For variables that contained multiple cat-
egories, such as the procedure performed, a reference category was
chosen to perform the multivariate analysis.
Results
There were 2588 patients available for analysis. The demo-
graphic data and the preoperative diagnoses are shown in
Table 1. Primary lung cancer, pulmonary metastasis, and
primary esophageal cancer accounted for 1988 (77%) of the
2588 cases. The 88 unspecified diagnoses included predom-
inantly local recurrences of lung and esophageal cancer and
primary pulmonary sarcomas.
The procedures performed are shown in Table 2. Lobec-
tomy represented 33% of the procedures performed; multi-
ple-wedge resections of 2 to 9 nodules, esophagectomy, and
single-wedge resections accounted for 42%. The remaining
procedures were chest wall or sternal resection, pneumo-
nectomy, mediastinal tumor resection and thymectomy,
multiple-wedge resection of more than 9 nodules, segmen-
tectomy, or bilobectomy.
AF occurred in 319 (12.3%) patients. Factors associated
with the development of AF were identified by using uni-
variate and multivariate analyses. The results of the univar-
iate analysis are shown in Table 3. Highly significant vari-
ables (P  .01) were age, sex, preoperative diagnosis,
weight loss, any smoking history, timing of smoking ces-
sation, hypertension, congestive heart failure, angina, ar-
rhythmias, peripheral vascular disease, COPD, prior thora-
cotomy, procedure performed, mediastinal node dissection,
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and intraoperative transfusion. The results of the univariate
analysis were used to construct the multivariate model. All
variables with a P value of .25 or less were included. In
addition to the variables that were highly significant in the
univariate analysis, neoadjuvant therapy, alcohol use, and
prior cardiac surgery fulfilled these criteria for inclusion in
the multivariate analysis. Two variables were excluded
from entry into the multivariate model. Preoperative diag-
nosis correlated closely with the procedure performed, and
therefore only one of these variables, the procedure per-
formed, was included in the multivariate analysis. For sim-
ilar reasons, any smoking history was included, but the
timing of smoking cessation was not. An additional reason
not to include the timing of smoking cessation was that
these data were missing for 138 patients. The multiple-
wedge variable was initially entered into the multivariate
model as 2 separate variables: multiple-wedge resections of
2 to 9 nodules and multiple-wedge resections of more than
9 nodules. Neither variable was associated with an increased
risk of AF, and therefore the 2 were combined into the
single variable of multiple wedges in the final multivariate
analysis.
The factors associated with an increased risk of AF on
multivariate analysis were age, male sex, history of conges-
tive heart failure, history of arrhythmias, history of periph-
eral vascular disease, the procedure performed (specifically,
mediastinal tumor resection or thymectomy, lobectomy, bi-
lobectomy, pneumonectomy, and esophagectomy), and any
intraoperative transfusion. The results of the multivariate
analysis are shown in Table 4. The variables of age and
procedure performed were both found to be significant (P
.01) by using the same reference groups as defined for the
univariate analysis (age 50 years and single-wedge resec-
tion, respectively). All age categories were significant pre-
dictors of AF compared with age of less than 50 years, and
increasing age was associated with increasing risk of AF.
With the procedures performed, increasing the volume of
lung resected was associated with increased risk of AF.
Lobectomy, bilobectomy, and pneumonectomy were asso-
ciated with progressively increasing relative risk. In addi-
tion, esophagectomy was a significant predictor of AF, with
a relative risk slightly less than that of a lobectomy. Resec-
tion of a mediastinal tumor or thymoma approached signif-
icance, with a relative risk similar to that of esophagectomy.
The incidence of AF was not dependent on the esopha-
geal resection technique. Transthoracic (Ivor Lewis) esoph-
agectomy was performed in 148 patients, transhiatal esoph-
agectomy in 118 patients, and 3-field esophagectomy in 54
patients. The AF incidence was 16.2%, 18.6%, and 16.7%,
respectively (P  .789).
The development of AF after thoracic surgery signifi-
cantly increased mortality rate (2.0% vs 7.5%, P  .001),
length of hospital stay (mean SD, 8.2 11.0 days vs 16.6
 18.6 days; P  .001), and hospital charges (mean 
SD, $28,325.98  $40,126.15 vs $56,426.57 
$88,924.53; P  .001). When patients without any com-
plications (n  1422) were compared with patients with
only AF (n  104), there still was a significant increase
in hospital cost (mean  SD, $21,425.38  $19,427.57
vs $27,859.38  $12,017.99; P  .001).
Discussion
The development of AF after general thoracic surgical pro-
cedures remains one of the most frequent complications.
This study identified age, male sex, a history of congestive
heart failure, arrhythmia or peripheral vascular disease, the
procedure performed, and the use of intraoperative transfu-
TABLE 2. Procedures performed on patients undergoing
major thoracic surgery
Procedure performed
No. of patients
(%), n  2588
Lobectomy 853 33
Multiple wedges (2-9 nodules) 406 16
Esophagectomy 324 13
Single wedge 347 13
Chest wall or sternum 170 7
Pneumonectomy 168 6
Mediastinal tumor resection or thymectomy 112 4
Multiple wedges (10 nodules) 77 3
Segmentectomy 79 3
Bilobectomy 52 2
TABLE 1. Demographic data and preoperative diagnoses in
2558 patients undergoing major thoracic surgery
Patient characteristic and diagnosis
No. of patients
(%), n  2588
Age, y
50 690 (27)
50-59 624 (24)
60-69 690 (27)
70 584 (23)
Sex
Male 1553 (60)
Female 1035 (40)
Preoperative diagnosis
Primary lung cancer 1015 (39)
Metastases, lung parenchyma 673 (26)
Primary esophageal cancer 310 (12)
Metastases, other 143 (6)
Lung, benign 137 (5)
Other 88 (3)
Mediastinal tumor 78 (3)
Pleural disease (mesothelioma) 65 (3)
Primary chest wall tumors 65 (3)
Esophagus, benign 14 (1)
AF 319 (12)
Mortality (30 d) 69 (3)
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TABLE 3. Results of univariate analysis to identify variables associated with AF after major thoracic surgery
Variable examined Total
No. of patients
P valuewith AF (%)
Age, y (reference: age 50 y) .01
50 690 244
50–59 624 45 7 .01
60–69 690 123 18 .01
70 584 127 22 .01
Sex .01
Male 1553 231 15
Female 1035 88 8
Preoperative diagnosis (reference: lung, benign) .01
Primary lung cancer 1015 193 19 .01
Metastases, lung parenchyma 673 28 4 .15
Primary esophageal cancer 310 49 16 .01
Metastases, other 143 8 6 .08
Lung, benign 137 2 2
Other (NOS)* 88 8 9 .05
Mediastinum 78 7 9 .02
Pleura (mesothelioma) 65 19 29 .01
Primary chest wall tumors 65 4 6 .09
Esophagus, benign 14 3 21 .01
Weight loss (reference: no weight loss)† .01
No weight loss 2207 252 12
8 kg 225 45 20 .01
8 kg 137 20 15 .26
Neoadjuvant therapy (reference: no preoperative therapy) .18
No preoperative therapy 1698 212 13
Chemotherapy 576 60 10 .19
Radiotherapy 23 2 9 .59
Chemotherapy and radiotherapy 291 45 16 .16
Any smoking history .01
Yes 1720 256 15
No 868 63 7
Timing of smoking cessation (reference: never smoked)‡ .01
Never smoked 868 63 7
0–14 d before the operation 217 17 8 .77
15 d to 1 mo before the operation 156 22 14 .01
1 mo to 12 mo before the operation 259 46 18 .01
12 mo to 5 y before the operation 610 88 14 .01
5 y before the operation 346 74 21 .01
Alcohol use (4 oz/d) .05
Yes 289 46 16
No 2299 273 12
Hypertension .01
Yes 734 126 17
No 1854 193 10
Congestive heart failure .01
Yes 25 9 36
No 2563 310 12
Angina .01
Yes 40 11 28
No 2548 308 12
Prior myocardial infarction .90
Yes 102 13 13
No 2486 306 12
Arrhythmias .01
Yes 117 35 30
No 2471 284 11
Diabetes .35
Yes 194 28 14
No 2394 291 12
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sion as predictors of postoperative AF. The patients evalu-
ated in this study represented a broad spectrum of general
thoracic surgical oncology patients. A wide variety of diag-
noses and procedures were examined, which allows gener-
alization of these results to other general thoracic practices.
Our 12.3% overall incidence of AF is similar to that in other
published reports.12-16 In addition, the associations of AF
with increased hospital stay and increased 30-day mortality
are also consistent with other published reports.4,5,12,17
Previous attempts to identify factors associated with the
development of AF after noncardiac thoracic surgery have
been performed. Although most have examined specific
subgroups of patients undergoing pulmonary resection, pri-
marily for lung cancer14-16,18 or esophagectomy,2 a few
investigators have examined a broader population of pa-
tients similar to our patient population.5,12,13 The most
frequent risk factors identified in these studies have been
increasing age and extent of pulmonary resection. Other
reported factors have included a history of hypertension,
ischemic changes on electrocardiography, cardiac enlarge-
ment, prior myocardial infarction, congestive heart failure,
mediastinal lymph node dissection, intraoperative cardiac
arrest, and need for repeat thoracotomy.
The association between age and AF was closely exam-
ined by Amar and colleagues.12 In their analysis of 527
patients undergoing lobectomy, pneumonectomy, or esoph-
agectomy over a 10-year period, they found incidences of
AF to be 4%, 8%, 14%, and 25% in patients younger than
50 years, 50 to 59 years, 60 to 69 years, and 70 or more
years of age, respectively. These findings are very similar to
those of our univariate analysis and support the association
of increasing incidence of AF with increasing age.
The association between the extent of pulmonary resec-
tion and AF has been identified by a number of investiga-
tors. Asamura and associates13 examined 267 nonesopha-
geal operations in a 1-year period and reported increasing
incidence of AF with increasing volume of lung resected.
Likewise, other investigators have found the highest inci-
TABLE 3. Continued
Variable examined Total
No. of patients
P valueWith AF (%)
Peripheral vascular disease .01
Yes 69 20 29
No 2519 299 12
COPD .01
Yes 250 43 17
No 2338 276 12
Prior cardiothoracic surgery .38
Yes 426 47 11
No 2162 272 13
Prior cardiac surgery .02
Yes 89 18 20
No 2499 301 12
Prior thoracotomy .01
Yes 308 23 7
No 2280 296 13
Procedure performed (reference: single wedge) .01
Single wedge 347 14 4
Multiple wedges 483 15 3 .47
Chest wall or sternum 170 6 4 .78
Mediastinal tumor resection or thymectomy 112 9 8 .10
Segmentectomy 79 6 8 .18
Lobectomy 853 151 18 .01
Bilobectomy 52 13 25 .01
Pneumonectomy 168 50 30 .01
Esophagectomy 324 55 17 .01
Mediastinal lymph node dissection .01
Yes 589 109 19
No 1999 210 11
Any intraoperative transfusion .01
Yes 346 67 19
No 2242 252 11
*Other includes patients with locally recurrent lung and esophageal cancer or primary pulmonary sarcomas.
†Data on 19 patients were missing, and therefore the total number analyzed was 2569.
‡Data on 132 patients were missing, and therefore the total number analyzed was 2456.
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dence of AF after pneumonectomy.14-16 Our analysis had
similar findings; in our study, however, it appeared that the
manipulation of the hilum might be as important as the total
volume of lung resected. This is a likely hypothesis because
it has been shown in patients with chronic AF that the
pulmonary veins are an important source of ectopic beats
that can initiate paroxysms of AF.19 Supporting evidence
from our analysis includes the similarity between the single-
wedge and multiple-wedge groups (neither was associated
with an increased risk of AF despite more lung being
resected in the multiple-wedge group) and the association of
AF with esophagectomy but not with chest wall or sternal
resections. However, patients with a large volume (9
wedges) of lung resected during multiple-wedge resections
or patients undergoing chest wall or sternal resections rep-
resented only 3% and 7%, respectively, of the total patient
population. Repeat analysis with a greater number of pa-
tients should be performed.
The association between male sex and AF has not been
commonly identified by other investigators, most likely
because of the small numbers of patients analyzed. Polanc-
zyk and coworkers5 examined 4181 patients undergoing
major noncardiac thoracic or abdominal procedures (hospi-
tal stay 2 days). Their multivariate analysis identified
male sex as a predictor of AF, with an odds ratio (odds ratio,
1.3; 95% confidence interval, 1.0 to 1.7; P  .04) similar to
that seen in our relative risk data. This association might be
explained by the effect of sex on immune response. One
hypothesis for the cause of postoperative AF is atrial or
pulmonary vein inflammation.20 After trauma, male patients
have an increased proinflammatory immune response com-
pared with that of female patients,21 and this might lead to
increased AF after surgical trauma.
The association between intraoperative transfusions and
AF found in our analysis has not been previously demon-
strated. Although it is possible that there are immunologic
effects of transfusion that lead to increased arrhythmias, it is
more likely that transfusions represent a marker of more
complex or difficult dissection.
The association of cardiac disease with AF has been
demonstrated inconsistently by other investigators.5,13,15,16
The selection criteria imposed by thoracic surgeons might
prevent patients with clinically relevant cardiac disease
from undergoing surgical intervention. This is certainly
demonstrated in our data because patients with congestive
heart failure, angina, prior myocardial infarction, arrhyth-
mias, or peripheral vascular disease represented only 1.0%,
1.5%, 3.9%, 4.5%, and 2.7%, respectively, of all the patients
examined. The common occurrence of AF after cardiac
surgery supports the association of cardiac disease with AF
after thoracic surgery.22,23 Our study demonstrated associ-
ations of congestive heart failure, arrhythmias, and periph-
eral vascular disease with AF. Both arrhythmias and con-
gestive heart failure have been identified by various
investigators. The association of peripheral vascular disease
and AF appears novel. Peripheral vascular disease is pre-
dominantly an inflammatory process, and therefore the in-
creased risk of AF in these patients, like male sex, might be
due to an intrinsic heightened inflammatory response.
The lack of association between hypertension and AF in
our analysis is also noteworthy. Other investigators have
shown this association, but their analyses were limited to
only 598 or 233 patients with lung cancer.15,18 Hypertension
occurred commonly in our population (28.4%) and was
associated with a higher incidence of AF by means of
univariate analysis; our multivariate model, however, failed
to demonstrate any association. The larger patient popula-
tion along with inclusion of many different diagnoses and
procedures in our analysis might have led to this difference.
The presence of COPD, the performance of a mediastinal
lymph node dissection, or the use of neoadjuvant chemo-
therapy, radiotherapy, or combined chemotherapy and ra-
diotherapy was not associated with the development of AF
in our study. Other investigators have found that the asso-
ciation between COPD and AF is inconsistent.24,25 The
definition of COPD might vary between different authors
and might lead to this inconsistency. Our definition was
based on the presence or absence of bronchodilator treat-
ment and not strict pulmonary function testing. Unfortu-
nately, data on pulmonary function were inconsistently col-
lected in our database during the 4-year period of this study.
Future analysis could allow inclusion of these parameters
into our multivariate model.
TABLE 4. Results of multivariate analysis to identify vari-
ables associated with AF after major thoracic surgery
Variable
Relative
risk
Confidence
interval P value
Age, y (reference: age 50 y)
50-59 1.70 1.01-2.88 .05
60-69 4.49 2.79-7.22 .01
70 5.30 3.28-8.59 .01
Sex 1.72 1.29-2.28 .01
Congestive heart failure 2.51 1.01-6.24 .05
Arrhythmias 1.92 1.22-3.02 .01
Peripheral vascular disease 1.65 0.93-2.92 .09
Procedure performed (reference:
single wedge)
Lobectomy 3.89 2.19-6.91 .01
Multiple wedges 0.87 0.41-1.85 .72
Esophagectomy 2.95 1.55-5.62 .01
Chest wall or sternum 0.92 0.34-2.47 .86
Pneumonectomy 8.91 4.59-17.28 .01
Mediastinal tumor resection or
thymectomy
Segmentectomy 1.57 0.57-4.29 .38
Bilobectomy 7.16 3.02-16.96 .01
Any intraoperative transfusion 1.39 0.98-1.98 .07
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Mediastinal node dissection was performed in 22.8% of
the patients in this study, and although it was associated
with a higher incidence of AF in the univariate analysis, it
was not predictive of AF in the multivariate model. Finally,
the use of neoadjuvant chemotherapy, radiotherapy, or com-
bination therapy was not associated with an increased risk
of AF. Investigators have shown a decrease in cardiac
perfusion and an increased frequency of cardiac symptoms,
ischemia, and mortality after left-breast radiation thera-
py.26-30 Our database does not collect information on the
dose and ports used during radiation therapy treatment.
Further analysis will be performed, with more detailed
attention paid to the cardiac radiation therapy dose and its
effect on the development of AF.
In conclusion, our analysis of 2588 patients undergoing a
variety of general thoracic procedures demonstrated an as-
sociation of AF with age, male sex, a history of congestive
heart failure, arrhythmia, peripheral vascular disease, the
procedure performed (specifically mediastinal tumor resec-
tion or thymectomy, lobectomy, bilobectomy, pneumonec-
tomy, and esophagectomy), and the use of intraoperative
transfusions. These results in this large cohort of patients
confirm the findings of a number of different investigators.
The identification of patients with a high risk of AF will
allow more directed application of pharmacologic and al-
ternative methods of prophylaxis.
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Discussion
Dr Robert J. Downey (New York, NY). I have just one brief
comment. To me, atrial arrhythmias are certainly common, but I
am unsure how severe they are. It occurs, in most experience, in
about 20% of patients, but most patients clear their arrhythmia by
the time they leave the hospital, and 98% of patients are reported
as having cleared it within 2 months. It also seems to occur in the
setting of many other problems quite commonly, meaning that if
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the patient becomes hypoxic with pneumonia, the atrial arrhythmia
might occur as a secondary event. So I am unsure of how severe
a complication it is.
I have 4 questions, and in the interest of time, I will collapse the
first and the third into a single question. A study like this is very
much dependent on both the definitions that you use and the
practices that are used at your institution. You required echocar-
diographic evidence for an atrial arrhythmia. That then was acted
on, somebody intervened, which would seem to limit the number,
lower the report, and perhaps understate the incidence. On the
other hand, your practice is that patients are monitored for 72 hours
after the operation, which is more than we do, and that would tend
to raise the incidence. Can you comment on how your definition
has affected the incidence that you report? Also, was there any
prophylaxis against arrhythmias used in any of these subgroups
that might have lowered the incidence?
Dr Vaporciyan. I will answer the second question first because
that is easier. There is no established method of prophylaxis at our
institution, except recently for the extrapleural pneumonectomies,
in which the incidence has been high. Patients received diltiazem
intraoperatively as a continuous infusion, which is continued post-
operatively. But that group actually represented a small portion of
the total number of patients, and therefore I do not think it had an
effect on the incidence of AF.
As far as the definitions, we have a stepdown unit that all of our
patients go to, where they are started automatically on a cardiac
monitor and an oxygen monitor. Therefore it is standard practice
for all our patients to be monitored. Any tachyarrhythmias iden-
tified there are followed up with a 12-lead echocardiogram. If a
diagnosis of AF with tachyarrhythmia is made, at that point the
patients are treated. That is our standard definition of how they
become identified.
Dr Downey. The second question is about the cause of atrial
arrhythmias. These have been attributed to either trauma to the
pulmonary vein and hence to the atrium and also to damage to the
sympathovagal fibers. It was interesting that the anatomic resec-
tions were associated with a higher incidence, which is what you
would expect, but the mediastinal lymph node dissection was not.
Do you have any comments on what your data show about the
possible causes of patients going into AF?
Dr Vaporciyan. The thought from the data is that the manip-
ulation of the hilum is probably the most important, specifically the
pulmonary veins, and that is something we are going to look into
in an animal model in the future. Mediastinal node dissection is not
done on all patients undergoing lobectomy because we have a high
percentage of metastasectomies at our institution, and some of
those require anatomic resections without the addition of medias-
tinal node dissection. Therefore I was able to dissect out medias-
tinal node dissection separate from the actual procedure per-
formed. The esophagectomies also have manipulation of the hilum
and the posterior left atrial wall, and they also lead to that cause as
well. The wedge resections and the actual amount of parenchyma
removed did not seem to make a difference. We segregated our
multiple-wedge resections by low numbers of wedge resections
and high numbers of wedge resections, and there were at least 80
or 90 patients who had greater than 10 wedge resections, which
would come close to anatomically about a lobectomy of removal
of lung parenchyma. Those patients had the same incidence of AF
as patients who underwent a single-wedge resection. Therefore I
think it is more the manipulation of the hilum than it is the actual lung
volume resected or vagal fibers from a mediastinal node dissection.
Dr Downey. My last question has to do with your multivariable
analysis. If I understand your data correctly, you are at high risk
for development of an atrial arrhythmia if you are male, if you are
over 60 years of age, or if you have an operation other than a
wedge resection or an isolated chest wall resection. Obviously I
think your risk factors are going to have to be brought together.
How are you planning to define the highest-risk group of patients
within the overall population?
Dr Vaporciyan. We actually looked at the way the model
predicts, and despite the fact that we have entered 2600 patients in
32 variables, it is still not as robust a model as it could be. It
actually predicts about 25% or 30% of the cases at best and usually
about 22% of the cases. Therefore there are obviously a lot of
factors that are involved that we were not able to detect, even with
2600 patients enrolled in this analysis. That being said, I think you
still can make the comment that patients undergoing pneumonec-
tomy who are male with advanced age have a high risk and should
be considered for some sort of prophylactic therapy.
Dr Daniel L. Miller (Atlanta, Ga). It is interesting that as we
go back and look at these AF data, there is not a lot of discussion
in regard to the onset of AF, which day it occurred, postoperative
day number 1, number 3, or number 5. Did you look at that at all
to see whether that made a difference in hospital stay, morbidity,
and so forth? And the second part of that, you had a correlation
with increased mortality, which a lot of studies with AF these days
do not. Was it that the patients that were already going down the
tubes on day 7 or 8 who had AF, that it was going on in a sequence?
If you could comment on both of those, that would be great.
Dr Vaporciyan. The database does not capture such detailed
hospital data. Essentially, at the time of discharge, all complica-
tions are entered in the database. We do not make a note of when
it happened. Just speaking anecdotally from taking care of the
patients, it is usually between 24 and 96 hours, about the second
hospital day to the fourth hospital day, that they occur.
In reference to the other aspect about how AF usually accom-
panies other complications, in the article we examined patients
with AF as their only complication, looked at the hospital charges
of those patients and the hospital stays of those patients, and
compared these values with those of the patients who had no other
complications. We found that when you exclude all other compli-
cations and look at patients who only had AF, there still was a
significant increase in cost and length of stay of about 30% to 50%.
We did not look at mortality yet, and we will look at that as well.
Dr David H. Harpole, Jr (Durham, NC). Dr Putnam and his
group at M. D. Anderson deserve credit for putting together this
very large prospective database to answer some of these questions.
This afternoon we have had a very nice presentation on probably
the largest series of pneumonectomies in North America and now
a nice prospective series looking at complications. The Society of
Thoracic Surgeons database general thoracic module is out. If we
want to learn more about these complications and ways to treat
them, I encourage all of you to participate in this database, and
hopefully over the next 10 years we will have a lot more articles
coming out in the Association on this subject.
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